A pilot study tracking immune cell subsets and activation profiles in adults with haemophagocytic lymphohistiocytosis treated with anakinra

Documenti analoghi

• Particular dysregulation of ‘don't eat me’ immune checkpoints in haemophagocytic lymphohistiocytosis
  di: Thomas Menter, et al.
  Pubblicazione: (2025)
• Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosis
  di: Katarina Zivkovic, et al.
  Pubblicazione: (2025)
• Goodbye etoposide? Taking the leap to ruxolitinib in haemophagocytic lymphohistiocytosis
  di: Samuel A. Merrill, et al.
  Pubblicazione: (2024)
• Hospitalization trends and clinical burden of paediatric haemophagocytic lymphohistiocytosis in a multicentre study in China
  di: Dilara Dilmurat, et al.
  Pubblicazione: (2025)
• Clinical and radiological spectrum of central nervous system restricted haemophagocytic lymphohistiocytosis
  di: Maha Zakariya Mohammed, et al.
  Pubblicazione: (2025)